ePRO Brightline-3 (1403-0006) 12+
ERT,INC
-
- Free
Screenshots
Description
The Boehringer Ingelheim ePRO App is intended to collect patient reported outcomes (Study Brightline-3, 1403-0006).
Boehringer Ingelheim ePRO Brightline-3 is intended to collect patient reported outcomes relating to a clinical trial (Trial Brightline-3 - 1403-0006). Patients must be given accounts by a participating site in order to log in to the app.
App Privacy
The developer, ERT,INC, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Health & Fitness
Privacy practices may vary based on, for example, the features you use or your age. Learn More
Information
- Provider
- ERT, INC
- Size
- 74 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 12.0 or later.
- iPad
- Requires iPadOS 12.0 or later.
- iPod touch
- Requires iOS 12.0 or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English
- Age Rating
- 12+ Infrequent/Mild Medical/Treatment Information
- Copyright
- © 2023 Clario, Boehringer-Ingelheim
- Price
- Free